Telomere Length Influences Cancer Cell Differentiation In Vivo

REFERENCES

• Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Niida H, Matsumoto T, Satoh H, Shiwa M, Tokutake Y, Furuichi Y, Shinkai Y. 1998. Severe growth defect in mouse cells lacking the telomerase RNA component. Nat. Genet. 19:203–206.
   PubMed Web of Science ®Google Scholar
• Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015.
   PubMed Web of Science ®Google Scholar
• Maser RS, DePinho RA. 2002. Connecting chromosomes, crisis, and cancer. Science 297:565–569.
   PubMed Web of Science ®Google Scholar
• Meeker AK, Hicks JL, Platz EA, March GE, Bennett CJ, Delannoy MJ, De Marzo AM. 2002. Telomere shortening is an early somatic DNA alteration in human prostate tumourigenesis. Cancer Res. 62:6405–6409.
   PubMedGoogle Scholar
• Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. 1996. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res. 56:218–222.
   PubMed Web of Science ®Google Scholar
• de Lange T. 2005. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19:2100–2110.
   PubMed Web of Science ®Google Scholar
• Marcand S, Gilson E, Shore D. 1997. A protein-counting mechanism for telomere length regulation in yeast. Science 275:986–990.
   PubMed Web of Science ®Google Scholar
• Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, Greider CW, DePinho RA. 1999. Short dysfunctional telomeres impair tumourigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97:515–525.
   PubMed Web of Science ®Google Scholar
• González-Suárez E, Samper E, Flores JM, Blasco MA. 2000. Telomerase-deficient mice with short telomeres are resistant to skin tumourigenesis. Nat. Genet. 26:114–117.
   PubMed Web of Science ®Google Scholar
• Feldser DM, Greider CW. 2007. Short telomeres limit tumour progression in vivo by inducing senescence. Cancer Cell 11:461–469.
   PubMedGoogle Scholar
• Taboski MA, Sealey DC, Dorrens J, Tayade C, Betts DH, Harrington L. 2012. Long telomeres bypass the requirement for telomere maintenance in human tumourigenesis. Cell Rep. 1:91–98.
   PubMedGoogle Scholar
• Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW, DePinho RA. 1999. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97:527–538.
   PubMed Web of Science ®Google Scholar
• Baur JA, Zou Y, Shay JW, Wright WE. 2001. Telomere position effect in human cells. Science 292:2075–2077.
   PubMed Web of Science ®Google Scholar
• Seimiya H, Muramatsu Y, Ohishi T, Tsuruo T. 2005. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Cancer Cell 7:25–37.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Kagawa H, Yamanashi Y, Sata T, Kawaguchi Y. 2003. Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo construction of an excisable bac. J. Virol. 77:1382–1391.
   PubMed Web of Science ®Google Scholar
• Meeker AK, Gage WR, Hicks JL, Simon I, Coffman JR, Platz EA, March GE, De Marzo AM. 2002. Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. Am. J. Pathol. 160:1259–1268.
   PubMed Web of Science ®Google Scholar
• Cookson JC, Dai F, Smith V, Heald RA, Laughton CA, Stevens MF, Burger AM. 2005. Pharmacodynamics of the G-quadruplex-stabilizing in human tumour cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents. Mol. Pharmacol. 68:1551–1558.
   PubMed Web of Science ®Google Scholar
• Nugent CI, Lundblad V. 1998. The telomerase reverse transcriptase: components and regulation. Genes Dev. 12:1073–1085.
   PubMed Web of Science ®Google Scholar
• Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, Chang W, Cheung P, Jun S, Artandi MK, Shah N, Kim SK, Artandi SE. 2008. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet. 4:e10. doi:10.1371/journal.pgen.0040010.
   PubMed Web of Science ®Google Scholar
• Maida Y, Yasukawa M, Furuuchi M, Lassmann T, Possemato R, Okamoto N, Kasim V, Hayashizaki Y, Hahn WC, Masutomi K. 2009. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 461:230–235.
   PubMed Web of Science ®Google Scholar
• Kim M, Xu L, Blackburn EH. 2003. Catalytically active human telomerase mutants with allele-specific biological properties. Exp. Cell Res. 288:277–287.
   PubMedGoogle Scholar
• Nagy A. 2000. Cre recombinase: the universal reagent for genome tailoring. Genesis 26:99–109.
   PubMed Web of Science ®Google Scholar
• Derycke LD, Bracke ME. 2004. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int. J. Dev. Biol. 48:463–476.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, An J, Horvath S, Gleave M, Rettig MB, Wainberg ZA, Reiter RE. 2010. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat. Med. 16:1414–1420.
   PubMed Web of Science ®Google Scholar
• Duarte CW, Willey CD, Zhi D, Cui X, Harris JJ, Vaughan LK, Mehta T, McCubrey RO, Khodarev NN, Weichselbaum RR, Gillespie GY. 2012. Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner. PLoS One 7:e29653. doi:10.1371/journal.pone.0029653.
   PubMedGoogle Scholar
• Kim S, Koga T, Isobe M, Kern BE, Yokochi T, Chin YE, Karsenty G, Taniguchi T, Takayanagi H. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Gene Dev. 3:1979–1991.
   Google Scholar
• Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, Zhao K. 2009. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4:80–93.
   PubMed Web of Science ®Google Scholar
• Martinez P, Thanasoula M, Carlos AR, Go‘mez-Lo'pez G, Tejera AM, Schoeftner S, Dominguez O, Pisano DG, Tarsounas M, Blasco MA. 2010. Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites. Nat. Cell Biol. 12:768–780.
   PubMed Web of Science ®Google Scholar
• Simonet T, Zaragosi LE, Philippe C, Lebrigand K, Schouteden C, Augereau A, Bauwens S, Ye J, Santagostino M, Giulotto E, Magdinier F, Horard B, Barbry P, Waldmann R, Gilson E. 2011. The human TTAGGG repeat factors 1 and 2 bind to a subset of interstitial telomeric sequences and satellite repeats. Cell Res. 21:1028–1038.
   PubMed Web of Science ®Google Scholar
• Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. 2008. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumour suppressor. PLoS Biol. 6:2853–2868.
   PubMed Web of Science ®Google Scholar
• Lou Z, Wei J, Riethman H, Baur JA, Voglauer R, Shay JW, Wright WE. 2009. Telomere length regulates ISG15 expression in human cells. Aging 1:608–621.
   PubMedGoogle Scholar
• Andersen JB, Hassel BA. 2006. The interferon regulated ubiquitin-like protein, ISG15, in tumourigenesis: friend or foe? Cytokine Growth Factor Rev. 17:411–421.
   PubMed Web of Science ®Google Scholar
• Satake H, Tamura K, Furihata M, Anchi T, Sakoda H, Kawada C, Iiyama T, Ashida S, Shuin T. 2010. The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer. Onc. Rep. 23:11–16.
   PubMedGoogle Scholar
• Arnoult N, Van Beneden A, Decottignies A. 2012. Telomere length regulates TERRA levels through increased trimethylation of telomeric H3K9 and HP1α. Nat. Struct. Mol. Biol. 19:948–956.
   PubMed Web of Science ®Google Scholar